Associations of MAOA-VNTR or 5HTT-LPR alleles with attention-deficit hyperactivity disorder symptoms are moderated by platelet monoamine oxidase B activity

Psychiatric Genetics

Volumn 22, Issue 1, 2012, Pages 42-45

  Wargelius, Hanna Linn ^a   Malmberg, Kerstin ^b   Larsson, Jan Olov ^b   Oreland, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

attention deficit hyperactivity disorder; conduct disorder; monoamine oxidase A; monoamine oxidase B; oppositional defiant disorder; platelet; serotonin transporter

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; SEROTONIN TRANSPORTER;

ADOLESCENT; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ASSESSMENT TOOL; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HUMAN; IMPULSIVENESS; KIDDIE SCHEDULE FOR AFFECTIVE DISORDERS AND SCHIZOPHRENIA FOR SCHOOL AGE CHILDREN PRESENT AND LIFETIME; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; STRUCTURED INTERVIEW; SYMPTOM; THROMBOCYTE; TWINS; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BLOOD PLATELETS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MINISATELLITE REPEATS; MONOAMINE OXIDASE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 84655167844     PISSN: 09558829     EISSN: 14735873     Source Type: Journal    
DOI: 10.1097/YPG.0b013e328347c1ab     Document Type: Article

References (38)

1. Af Klinteberg B, Levander SE, Oreland L, Asberg M, Schalling D (1987). Neuropsychological correlates of platelet monoamine oxidase (MAO) activity in female and male subjects. Biol Psychol 24:237-252. (Pubitemid 17151240)
2. Akhondzadeh S, Tavakolian R, Davari-Ashtiani R, Arabgol F, Amini H (2003). Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 27:841-845. (Pubitemid 36966767)
3. Arnsten AF (2009). Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 23 (Suppl 1):33-41.
4. Baker GB, Bornstein RA, Rouget AC, Ashton SE, Van Muyden JC, Coutts RT (1991). Phenylethylaminergic mechanisms in attention-deficit disorder. Biol Psychiatry 29:15-22.
5. Biederman J, Kim JW, Doyle AE, Mick E, Fagerness J, Smoller JW, Faraone SV (2008). Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. Am J Med Genet B Neuropsychiatr Genet 147B:1511-1518.
6. Bortolato M, Godar SC, Davarian S, Chen K, Shih JC (2009). Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice. Neuropsychopharmacology 34:2746-2757.
7. Canli T, Lesch KP (2007). Long story short: the serotonin transporter in emotion regulation and social cognition. Nat Neurosci 10:1103-1109. (Pubitemid 47339957)
8. Coccini T, Crevani A, Rossi G, Assandri F, Balottin U, Nardo RD, Manzo L (2009). Reduced platelet monoamine oxidase type B activity and lymphocyte muscarinic receptor binding in unmedicated children with attention deficit hyperactivity disorder. Biomarkers 14:513-522.
9. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, et al.1996). A novel functional polymorphism within the promoter of the serotonin transportergene: possible role in susceptibility to affective disorders. Mol Psychiatry 1:453-460. (Pubitemid 126439785)
10. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, et al.1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624. (Pubitemid 29139976)
11. Domschke K, Sheehan K, Lowe N, Kirley A, Mullins C, O'Sullivan R, et al.2005). Association analysis of the monoamine oxidase A and B genes with attention deficit hyperactivity disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet B Neuropsychiatr Genet 134B:110-114. (Pubitemid 40416788)
12. Heiser P, Dempfle A, Friedel S, Konrad K, Hinney A, Kiefl H, et al.2007). Familybased association study of serotonergic candidate genes and attention-deficit/ hyperactivity disorder in a German sample. J Neural Transm 114:513-521. (Pubitemid 46474866)
13. Janssen PA, Leysen JE, Megens AA, Awouters FH (1999). Does phenylethylamine act as an endogenous amphetamine in some patients? Int J Neuropsychopharmacol 2:229-240.
14. Jarrett MA, Ollendick TH (2008). A conceptual review of the comorbidity of attention-deficit/hyperactivity disorder and anxiety: implications for future research and practice. Clin Psychol Rev 28:1266-1280.
15. Lawson DC, Turic D, Langley K, Pay HM, Govan CF, Norton N, et al.2003). Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 116B: 84-89. (Pubitemid 37063620)
16. Li J,Wang Y, Zhou R, Zhang H, Yang L,Wang B, Faraone SV (2007). Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet 144B:14-19. (Pubitemid 46122633)
17. Lichtenstein P, Tuvblad C, Larsson H, Carlstrom E (2007). The Swedish Twin study of CHild and Adolescent Development: the TCHAD-study. Twin Res Hum Genet 10:67-73. (Pubitemid 46423377)
18. Lung FW, Yang P, Cheng TS, Kao WT (2006). No allele variation of the MAOA gene promoter in male Chinese subjects with attention deficit hyperactivity disorder. Neuropsychobiology 54:147-151.
19. Malmberg K, Wargelius HL, Lichtenstein P, Oreland L, Larsson JO (2008). ADHD and Disruptive Behavior scores: associations with MAO-A and 5-HTT genes and with platelet MAO-B activity in adolescents. BMC Psychiatry 8:28.
20. Manor I, Tyano S, Mel E, Eisenberg J, Bachner-Melman R, Kotler M, Ebstein RP (2002). Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA). Mol Psychiatry 7:626-632.
21. Manuck SB, Flory JD, Ferrell RE, Mann JJ, Muldoon MF (2000). A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res 95:9-23. (Pubitemid 30445200)
22. Meyer-Lindenberg A, Buckholtz JW, Kolachana BARH, Pezawas L, Blasi G, Wabnitz A, et al.2006). Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci USA 103:6269-6274.
23. Murata M, Katagiri N, Ishida K, Abe K, Ishikawa M, Utsunomiya I, et al.2009). Effect of beta-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex. Brain Res 1269:40-46.
24. Nilsson KW, Sjoberg RL, Wargelius HL, Leppert J, Lindstrom L, Oreland L (2007). The monoamine oxidase A (MAO-A) gene, family function and maltreatment as predictors of destructive behaviour during male adolescent alcohol consumption. Addiction 102:389-398. (Pubitemid 46239364)
25. Nilsson KW,Wargelius HL, Sjoberg RL, Leppert J, Oreland L (2008). The MAO-A gene, platelet MAO-B activity and psychosocial environment in adolescent female alcohol-related problem behaviour. Drug Alcohol Depend 93:51-62. (Pubitemid 350236589)
26. Oreland L (1991). Monoamine oxidase, dopamine and Parkinson's disease. Acta Neurol Scand Suppl 136:60-65.
27. Oreland L (2004). Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection. Neurotoxicology 25:79-89. (Pubitemid 38044171)
28. Paaver M, Nordquist N, Parik J, Harro M, Oreland L, Harro J (2007). Platelet MAO activity and the 5-HTT gene promoter polymorphism are associated with impulsivity and cognitive style in visual information processing. Psychopharmacology (Berl) 194:545-554. (Pubitemid 47492997)
29. Pedersen NL, Oreland L, Reynolds C, McClearn GE (1993). Importance of genetic effects for monoamine oxidase activity in thrombocytes in twins reared apart and twins reared together. Psychiatry Res 46:239-251. (Pubitemid 23121525)
30. Qian QJ, Liu J,Wang YF, Yang L, Guan LL, Faraone SV (2009). Attention deficit hyperactivity disorder comorbid oppositional defiant disorder and its predominately inattentive type: evidence for an association with COMT but not MAOA in a Chinese sample. Behav Brain Funct 5:8.
31. Rao ML, Kolsch H (2003). Effects of estrogen on brain development and neuroprotection: implications for negative symptoms in schizophrenia. Psychoneuroendocrinology 28 (Suppl 2):83-96. (Pubitemid 36332231)
32. Rommelse NN, Altink ME, Arias-Vasquez A,Buschgens CJ, Fliers E, Faraone SV, et al.2008). Differential association between MAOA, ADHD and neuropsychological functioning in boys and girls. Am J Med Genet B Neuropsychiatr Genet 147B:1524-1530.
33. Rubinstein S, Malone MA, Roberts W, Logan WJ (2006). Placebo-controlled study examining effects of selegiline in children with attention-deficit/ hyperactivity disorder. J Child Adolesc Psychopharmacol 16:404-415. (Pubitemid 44681461)
34. Schatz DB, Rostain AL (2006). ADHD with comorbid anxiety: a review of the current literature. J Atten Disord 10:141-149.
35. Stoff DM, Friedman E, Pollock L, Vitiello B, Kendall PC, Bridger WH (1989). Elevated platelet MAO is related to impulsivity in disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry 28:754-760. (Pubitemid 19239929)
36. Vitalis T, Alvarez C, Chen K, Shih JC, Gaspar P, Cases O (2003). Developmental expression pattern of monoamine oxidases in sensory organs and neural crest derivatives. J Comp Neurol 464:392-403. (Pubitemid 36988790)
37. Wakschlag LS, Kistner EO, Pine DS, Biesecker G, Pickett KE, Skol AD, et al.2009). Interaction of prenatal exposure to cigarettes and MAOA genotype in pathways to youth antisocial behavior. Mol Psychiatry 15:928-937.
38. Zametkin AJ, Karoum F, Rapoport JL, Brown GL, Wyatt RJ (1984). Phenylethylamine excretion in attention-deficit disorder. J Am Acad Child Psychiatry 23:310-314.